(Q28366032)

English

A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom (English)

0 references

0 references

1 reference

1 reference

R J Sambrook

1

0 references

D J Girling

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 June 2001

0 references

published in

British Journal of Cancer

0 references

volume

84

0 references

issue

11

0 references

page(s)

1447-52

0 references

cites work

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

20 March 2017

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

29 September 2017

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

29 September 2017

Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

29 September 2017

New drugs for treating small cell lung cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

29 September 2017

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

29 September 2017

Treatment of small cell lung cancer: the state of the art.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

2 June 2018

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363653

retrieved

27 November 2018

Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11384091

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11384091

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11384091

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11384091

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1054/BJOC.2001.1817

0 references

Dimensions Publication ID

1048309888

0 references

PMC publication ID

2363653

0 references

PubMed publication ID

11384091

0 references

ResearchGate publication ID

11955150

0 references

(Q28366032)

A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)